---
figid: PMC11763799__cancers-17-00248-g001
figtitle: EGFR signaling pathway scheme
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11763799
filename: cancers-17-00248-g001.jpg
figlink: /pmc/articles/PMC11763799/figure/F1/
number: F1
caption: 'EGFR signaling pathway scheme. (A) The cytoplasmic EGFR pathway is consisted
  of four major modules: RAS-BRAF-MEK-ERK-MYC, PI3K-AKT-mTOR, PLC-γ-CaMK/PKC and STAT3s.
  Activated pathways ensure the regulation of gene expression of cell proliferation,
  metastasis, chemoresistance and radioresistance. (B) The EGFR nuclear pathway can
  be activated by various ligands. Nuclear EGFR contributes to the increased expression
  of cyclin D1 and B-Myb, thereby contributing to the acceleration of the G1/S cell
  cycle, and by increasing the expression of iNOS, it contributes to tumor proliferation
  and metastasis. Following DNA damage and oxidative/heat stress, EGFR enters the
  cell nucleus and interacts with DNA-PK, leading to DNA repair mechanisms and radioresistance.
  RAS: rat sarcoma virus, BRAF: v-Raf murine sarcoma viral oncogene homolog B1, MEK:
  mitogen-activated protein kinase, ERK: extracellular signal-regulated kinase, MYC:
  myelocytoma proto-oncogene, PI3K: phosphatidylinositol 3-kinase, AKT: protein kinase
  B, mTOR: mammalian target of rapamycin, PLC-γ: phospholipase C, γ isoform, CaMK/PKC:
  calcium/calmodulin-dependent kinases/protein kinase C, STAT3: signal transducer
  and activator of transcription 3, PTEN: phosphatase and tensin homolog, E2F1: E2F
  transcription factor 1, DNA-PK: DNA-dependent protein kinase, PIP2: phosphatidylinositol
  4,5-bisphosphate, IP3: inositol 1,4,5-trisphosphate, DAG: 1,2-diacylglycerol'
papertitle: 'Dynamic Multilevel Regulation of EGFR, KRAS, and MYC Oncogenes: Driving
  Cancer Cell Proliferation Through (Epi)Genetic and Post-Transcriptional/Translational
  Pathways'
reftext: Mario Seres, et al. Cancers (Basel). 2025 Jan;17(2).
year: '2025'
doi: 10.3390/cancers17020248
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: MYC | EGFR | KRAS | epigenetic and non-epigenetic regulation
automl_pathway: 0.9442077
figid_alias: PMC11763799__F1
figtype: Figure
redirect_from: /figures/PMC11763799__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11763799__cancers-17-00248-g001.html
  '@type': Dataset
  description: 'EGFR signaling pathway scheme. (A) The cytoplasmic EGFR pathway is
    consisted of four major modules: RAS-BRAF-MEK-ERK-MYC, PI3K-AKT-mTOR, PLC-γ-CaMK/PKC
    and STAT3s. Activated pathways ensure the regulation of gene expression of cell
    proliferation, metastasis, chemoresistance and radioresistance. (B) The EGFR nuclear
    pathway can be activated by various ligands. Nuclear EGFR contributes to the increased
    expression of cyclin D1 and B-Myb, thereby contributing to the acceleration of
    the G1/S cell cycle, and by increasing the expression of iNOS, it contributes
    to tumor proliferation and metastasis. Following DNA damage and oxidative/heat
    stress, EGFR enters the cell nucleus and interacts with DNA-PK, leading to DNA
    repair mechanisms and radioresistance. RAS: rat sarcoma virus, BRAF: v-Raf murine
    sarcoma viral oncogene homolog B1, MEK: mitogen-activated protein kinase, ERK:
    extracellular signal-regulated kinase, MYC: myelocytoma proto-oncogene, PI3K:
    phosphatidylinositol 3-kinase, AKT: protein kinase B, mTOR: mammalian target of
    rapamycin, PLC-γ: phospholipase C, γ isoform, CaMK/PKC: calcium/calmodulin-dependent
    kinases/protein kinase C, STAT3: signal transducer and activator of transcription
    3, PTEN: phosphatase and tensin homolog, E2F1: E2F transcription factor 1, DNA-PK:
    DNA-dependent protein kinase, PIP2: phosphatidylinositol 4,5-bisphosphate, IP3:
    inositol 1,4,5-trisphosphate, DAG: 1,2-diacylglycerol'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - KRAS
  - HRAS
  - NRAS
  - BRAF
  - PTEN
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - MYC
  - MTOR
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - EGF
  - STAT3
  - E2F1
  - UBE2L3
  - PRKDC
  - MYBL2
  - NOS2
  - ISYNA1
  - RAS
  - MEK
  - EGF
  - vitamin D
---
